1. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
2. Risk, Benefit, and Fairness in a Big Data World
3. Reducing patient re-identification risk for laboratory results within research datasets
4. 4. See (last visited February 27, 2020); Art. 4 GDPR, available at (last visited February 27, 2020).
5. 11. Sweeney, L. , Yoo, J. S. , Perovich, L. , Boronow, K. E. , Brown, P. , and Brody, J. G. , "Re-identification Risks in HIPAA Safe Harbor Data: A Study of Data from One Environmental Health Study," Technology Science (2017), available at (last visited March 13, 2020)